Clinical Trial Update: Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 study completed comparing once-daily versus twice-daily tacrolimus in stable kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of British Columbia | Conditions: Renal Disease, Renal Transplant | Phase 4 | Status: COMPLETED